Arcellx, Inc. financial data

Symbol
ACLX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
800 Bridge Parkway, Redwood City, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 424 % -15.1%
Debt-to-equity 84.4 % +55.4%
Return On Equity -13.1 % +81.6%
Return On Assets -7.11 % +84.6%
Operating Margin -57.1 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.5 M shares +11.8%
Common Stock, Shares, Outstanding 53.3 M shares +11.4%
Entity Public Float 1.3 B USD +187%
Common Stock, Value, Issued 53 K USD +10.4%
Weighted Average Number of Shares Outstanding, Basic 52.8 M shares +12.8%
Weighted Average Number of Shares Outstanding, Diluted 52.8 M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 132 M USD +119%
Research and Development Expense 133 M USD -19%
General and Administrative Expense 73.7 M USD +50%
Operating Income (Loss) -75.2 M USD +61.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -50.2 M USD +73.5%
Income Tax Expense (Benefit) 334 K USD +1.52%
Net Income (Loss) Attributable to Parent -50.5 M USD +73.4%
Earnings Per Share, Basic -1.03 USD/shares +77.2%
Earnings Per Share, Diluted -1.03 USD/shares +77.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 155 M USD -43.8%
Marketable Securities, Current 419 M USD +62.1%
Cash, Cash Equivalents, and Short-term Investments 483 M USD
Assets, Current 589 M USD +3.04%
Property, Plant and Equipment, Net 44.9 M USD +212%
Operating Lease, Right-of-Use Asset 24.2 M USD -18.4%
Assets 780 M USD +25.2%
Accounts Payable, Current 3.1 M USD -31.6%
Accrued Liabilities, Current 33.9 M USD +142%
Contract with Customer, Liability, Current 31.2 M USD -70.9%
Liabilities, Current 108 M USD -35%
Contract with Customer, Liability, Noncurrent 112 M USD +5.96%
Operating Lease, Liability, Noncurrent 47.7 M USD +49%
Other Liabilities, Noncurrent 15.5 M USD
Liabilities 283 M USD -11.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -512 K USD -695%
Retained Earnings (Accumulated Deficit) -397 M USD -14.6%
Stockholders' Equity Attributable to Parent 497 M USD +63.5%
Liabilities and Equity 780 M USD +25.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.9 M USD -118%
Net Cash Provided by (Used in) Financing Activities -2.99 M USD -103%
Net Cash Provided by (Used in) Investing Activities -207 M USD -210%
Common Stock, Shares Authorized 1 B shares 0%
Common Stock, Shares, Issued 53.3 M shares +11.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -242 M USD -215%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 157 M USD -43.3%
Deferred Tax Assets, Valuation Allowance 91.8 M USD +2.19%
Deferred Tax Assets, Gross 104 M USD +5.76%
Operating Lease, Liability 58.3 M USD +70.6%
Payments to Acquire Property, Plant, and Equipment 6.43 M USD +556%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -51.1 M USD +73.1%
Lessee, Operating Lease, Liability, to be Paid 95.5 M USD +2.48%
Property, Plant and Equipment, Gross 48 M USD +227%
Operating Lease, Liability, Current 7.15 M USD +44.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.5 M USD +40.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.84 M USD +160%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35.3 M USD -8.83%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.75 M USD +7.23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200 M shares 0%
Unrecognized Tax Benefits 3.45 M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.01 M USD +7.12%
Operating Lease, Payments 757 K USD +267%
Additional Paid in Capital 894 M USD +37.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 826 K USD +91.2%
Deferred Tax Assets, Net of Valuation Allowance 11.7 M USD +45.7%
Share-based Payment Arrangement, Expense 41.8 M USD +94%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%